Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
3.830
-0.050 (-1.29%)
Feb 4, 2026, 4:00 PM EST - Market closed
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $92.19 million as of February 5, 2026. Its market cap has increased by 156.19% in one year.
Market Cap
92.19M
Enterprise Value
76.45M
1-Year Change
156.19%
Ranking
Category
Stock Price
$3.83
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $92.19M, a decrease of -89.22%. That is a compound annual growth rate of -27.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 92.19M | -7.93% |
| Dec 31, 2025 | 100.14M | 242.63% |
| Dec 31, 2024 | 29.23M | -34.32% |
| Dec 29, 2023 | 44.50M | -66.30% |
| Dec 30, 2022 | 132.04M | -70.64% |
| Dec 31, 2021 | 449.68M | 2.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 100.19M |
| Fortress Biotech | 99.79M |
| Coya Therapeutics | 99.50M |
| Agenus | 99.30M |
| Champions Oncology | 99.04M |
| Anixa Biosciences | 97.46M |
| aTyr Pharma | 95.72M |
| Cassava Sciences | 94.93M |